Buoyed By Strong Results, Bayer Stresses Asia Pacific As Driver Of Growth
This article was originally published in The Pink Sheet Daily
Asia-Pacific sales grew by 5.8%, at €604 million, in 2010, surpassing the global growth of less than 1% for parent Bayer AG.
You may also be interested in...
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.